{"podcast":{"title":"Business Of Biotech","slug":"business-of-biotech-123501","podcast_index_feed_id":123501,"rss_url":"https://rss.buzzsprout.com/1011661.rss","website_url":"https://www.bioprocessonline.com/solution/the-business-of-biotech-podcast","image_url":"https://storage.buzzsprout.com/35u0bccu9j9xpr9zrrjias54otax?.jpg","author":"Ben Comer","episode_count":324,"summary":"The Business of Biotech is the pod dedicated to leaders of emerging biopharma firms. SUBSCRIBE to our new newsletter at www.bioprocessonline.com/bob. We bring you insight into organizational, finance and funding, HR, clinical, manufacturing, regulatory, and commercial challenges you’ll face as you navigate your company from an idea to success in the clinic and beyond. Each episode features guest commentary and best practices from accomplished founders and biopharma industry luminaries. The Business of Biotech is produced by Life Science Connect.","last_synced_at":"2026-09-14T18:21:24.973502+00:00","page_url":"https://stenobird.com/podcast/business-of-biotech-123501"},"episode":{"title":"Picking Biotech Winners Beyond The Hype Cycle With Andera Partners' Olivier Litzka","slug":"picking-biotech-winners-beyond-the-hype-cycle-with-andera-partners-olivier-litzka","published_at":"2026-08-31T10:00:00+00:00","page_url":"https://stenobird.com/podcast/business-of-biotech-123501/picking-biotech-winners-beyond-the-hype-cycle-with-andera-partners-olivier-litzka","show_page_url":"https://stenobird.com/podcast/business-of-biotech-123501","url":"https://www.buzzsprout.com/1011661/episodes/19707084-picking-biotech-winners-beyond-the-hype-cycle-with-andera-partners-olivier-litzka.mp3","audio_url":"https://www.buzzsprout.com/1011661/episodes/19707084-picking-biotech-winners-beyond-the-hype-cycle-with-andera-partners-olivier-litzka.mp3","summary":"We love to hear from our listeners. Send us a message. On this week's episode of the Business of Biotech, Olivier Litzka, Partner at Andera Partners, talks about what it really takes for biotech companies to attract capital, stay focused, and survive the moments when biology and execution punch back. Olivia also discusses a collaborative effort in Europe to create a stronger public market and investor base, and what the emergence of AI and Chinese biotech means for building tomorrow's biotec...","meta_description":"We love to hear from our listeners. Send us a message. On this week's episode of the Business of Biotech, Olivier Litzka, Partner at Andera Partners, talk…","key_points":[],"chapters":[],"topics":[],"duration_seconds":3490,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/business-of-biotech-123501/episodes/picking-biotech-winners-beyond-the-hype-cycle-with-andera-partners-olivier-litzka/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/business-of-biotech-123501/picking-biotech-winners-beyond-the-hype-cycle-with-andera-partners-olivier-litzka.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]}}